Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5025784
Reference Type
Journal Article
Title
The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational
Cholangiocarcinoma
Author(s)
Kinoshita, M; Takemura, S; Tanaka, S; Shinkawa, H; Hamano, G; Ito, T; Koda, M; Aota, T; Nakanuma, Y; Sato, Y; Nakamori, S; Arimoto, A; Yamamoto, T; Toyokawa, H; Kubo, S
Year
2018
Volume
19
Issue
7
Page Numbers
1753-1759
Language
English
PMID
30049183
DOI
10.22034/APJCP.2018.19.7.1753
Abstract
Objective: The present study aimed to identify the clinical significance of fluorine-18 fluorodeoxyglucose positron
emission tomography (FDG-PET) imaging in patients with occupational cholangiocarcinoma. Methods: This study
included 10 men with occupational cholangiocarcinoma who were former or current workers at a printing company in
Osaka, Japan. Of the 10 patients, 2 had 2 main tumors and 1 had 3 main tumors. Twelve FDG-PET imaging findings
in the 10 patients could be analyzed. We evaluated the relationships between FDG-PET imaging parameters and
clinicopathological findings of occupational cholangiocarcinoma. Results: Abnormal FDG uptake was observed in 8 of
the 14 main tumors, with maximum standardized uptake values ranging from 2.9 to 11.0, and the sensitivity was 57.1%.
Four patients had lymph node metastases, and abnormal marrow uptake was detected in all these patients. Although
precancerous lesions, such as biliary intraepithelial neoplasia (BilIN) and intraductal papillary neoplasm of the bile
duct (IPNB) without any invasion, were not detected, abnormal FDG uptake was demonstrated in 2 of 4 patients with
IPNB having an associated invasive carcinoma.Conclusions: Although FDG-PET may be useful for assessing tumor
progression factors, such as lymph node metastasis, it cannot accurately detect precancerous lesions, such as BilIN
and IPNB without invasive carcinoma.
Tag
IRIS
•
Chromium VI
2019 Lit Search GI Occupational
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity